Brand name: Aquasol E
Drug class: Vitamin E
ATC class: A11HA03
VA class: VT600
CAS number: 1406-18-4

Medically reviewed by Drugs.com on Dec 22, 2023. Written by ASHP.

Introduction

Fat-soluble vitamin; an antioxidant.

Uses for Vitamin E

Dietary Requirements

Adequate intake needed to prevent vitamin E deficiency and peripheral neuropathy associated with vitamin E deficiency.

Adequate intake of vitamin E usually can be accomplished through consumption of foodstuffs containing fat. Vitamin E is principally obtained from vegetable oils, unprocessed cereal grains, nuts, fruits, vegetables, and meats (especially those high in fat).

Recommended Dietary Allowance (RDA) in adults is based on induced vitamin E deficiency and the correlation between hydrogen peroxide-induced erythrocyte hemolysis and plasma α-tocopherol concentrations.

Adequate Intake (AI) established for infants ≤6 months of age is based on observed mean vitamin E intake of infants fed principally human milk; AI for infants 7–12 months of age is based on the AI for younger infants.

Vitamin E Deficiency

Treatment of vitamin E deficiency (e.g., patients with genetic abnormalities in α-tocopherol transfer protein, fat malabsorption syndromes, or protein-calorie malnutrition).

Alzheimer’s Disease

Has been evaluated in a dosage of 2000 units daily for the palliative treatment of moderately severe dementia of the Alzheimer’s type^{† [off-label]} (Alzheimer’s disease, presenile or senile dementia). Not recommended for the treatment of cognitive symptoms of dementia because of limited evidence of efficacy and safety concerns. (See Mortality under Cautions.)

Cardiovascular Risk Reduction

Current data does not support use of vitamin E supplements to reduce the risk of cardiovascular disease^{† [off-label]}.

Macular Degeneration

Suggested as a component of high-dose antioxidant supplements with zinc to reduce risk of developing advanced age-related macular degeneration^{† [off-label]} in high-risk patients (i.e., those with intermediate stage age-related macular degeneration or advanced stage macular degeneration in only one eye).

Use in Neonates

Has been used to prevent vitamin E deficiency in premature neonates^{† [off-label]}.

Pharmacologic doses of vitamin E not recommended for prevention or treatment of retinopathy of prematurity^{† [off-label]}, bronchopulmonary dysplasia^†, or intraventricular hemorrhage^†.

Cancer Risk Reduction

Use of vitamin E alone in conjunction with selenium does not decrease the risk of prostate cancer^†.

Current data does not support the use of vitamin E supplements to reduce the risk of cancer^†.

Prophylaxis of Tardive Dyskinesia

Has been used to reduce the risk of tardive dyskinesia^† associated with use of antipsychotic agents.

Vitamin E Dosage and Administration

Administration

Usually administered orally; may administer parenterally as a component of a multivitamin injection.

Oral Administration

Consider water-miscible oral vitamin E preparations for patients with malabsorption syndromes.

Dosage

Dosage expressed in terms of USP or International Units (IU).

Adequate Intake (AI) and Recommended Dietary Allowance (RDA) are expressed in mg in terms of the 2R-stereoisomeric forms of α-tocopherol.

Pediatric Patients

Dietary and Replacement Requirements

Oral

Infants ≤6 months of age: Recommended AI is 4 mg (0.6 mg/kg) of α-tocopherol daily.

Infants 7–12 months of age: Recommended AI is 5 mg (0.6 mg/kg) of α-tocopherol daily.

Children 1–3 years of age: RDA is 6 mg of α-tocopherol daily.

Children 4–8 years of age: RDA is 7 mg of α-tocopherol daily.

Children 9–13 years of age: RDA is 11 mg of α-tocopherol daily.

Children 14–18 years of age: RDA is 15 mg of α-tocopherol daily.

Vitamin E Deficiency

Oral

1 unit/kg daily (given as a water-miscible preparation) has been used in children with malabsorption syndromes.

Preterm, low-birthweight neonates weighing <1 kg at birth: 6–12 units/kg daily has been used to prevent vitamin E deficiency.

Adults

Dietary and Replacement Requirements

Oral

Men and women ≥19 years of age: RDA is 15 mg of α-tocopherol daily.

Vitamin E Deficiency

Oral

60–75 units daily.

Macular Degeneration†

Oral

400 units in combination with ascorbic acid 500 mg, beta carotene 15 mg, and zinc (as zinc oxide) 80 mg, with copper (as cupric oxide) 2 mg (to prevent anemia) daily has been used.

Tardive Dyskinesia†

Oral

400–800 units daily has been recommended.

Prescribing Limits

Adults

Oral

≥400 units daily generally not recommended. (See Mortality under Cautions.)

Special Populations

Pregnant Women

RDA for pregnant women 14–50 years of age is 15 mg of α-tocopherol daily.

Lactating Women

RDA for lactating women 14–50 years of age is 19 mg of α-tocopherol daily.

Cautions for Vitamin E

Contraindications

No known contraindications.

Warnings/Precautions

Warnings

Mortality

Long-term administration (>1 year) of high doses of vitamin E (≥400 units daily) may increase all-cause mortality.

Specific Populations

Pregnancy

Category A.

Lactation

Distributed into human milk.

Common Adverse Effects

Usually nontoxic at therapeutic doses.

Drug Interactions

Specific Drugs

Vitamin E Pharmacokinetics

Absorption

Bioavailability

Absorption from the GI tract depends on biliary and pancreatic secretions, micelle formation, uptake into erythrocytes, and chylomicron secretion. Not well absorbed; 20–60% absorbed from dietary sources. Fraction absorbed decreases as dosage increases.

Distribution

Extent

Readily distributed into all tissues and stored in adipose tissue.

Crosses the placenta. Distributed into human milk.

Secreted from the liver in very-low-density lipoproteins (VLDLs); only the R-stereoisomer of α-tocopherol is secreted by the liver.

Elimination

Metabolism

Extensively metabolized, principally in the liver, to glucuronides of tocopheronic acid and its γ-lactone.

Elimination Route

Excreted principally in the feces via biliary excretion; also excreted in urine.

Stability

Storage

Oral

Cool dry place.

Actions

• Chain-breaking antioxidant that prevents propagation of free-radical reactions (e.g., lipid peroxidation); scavenges peroxyl radicals; protects polyunsaturated fatty acids (PUFAs) and other oxygen-sensitive substances such as vitamin A and ascorbic acid from oxidation.

• Has been suggested that the antioxidant effects of the vitamin may have beneficial effects in delaying the onset or slowing the progress of Alzheimer’s changes.

• May enhance immune response in healthy geriatric individuals.

Advice to Patients

• Importance of informing clinicians of existing or contemplated therapy, including prescription and OTC drugs and dietary or herbal supplements, as well as concomitant illnesses.

• Importance of proper dietary habits, including taking appropriate AI or RDA of vitamin E.

• Importance of women informing clinicians if they are or plan to become pregnant or plan to breast-feed.

• Importance of informing patients of other important precautionary information. (See Cautions.)

Preparations

Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.

Please refer to the ASHP Drug Shortages Resource Center for information on shortages of one or more of these preparations.

* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name

Reload page with references included

Frequently asked questions

• What are antioxidants and should you take supplements?

Medical Disclaimer